^




Show legend
Group by Gene:
Include preclinical:

0
Bifunctional alkylating agent, Tubulin polymerization promoter
paclitaxel + ifosfamide
1
Bifunctional alkylating agent
ifosfamide
2
Topoisomerase II inhibitor, RNA synthesis inhibitor
dactinomycin
3
Tubulin polymerization promoter
paclitaxel
4
Tubulin polymerization promoter, DNA synthesis inhibitor
paclitaxel + gemcitabine
5
Topoisomerase II inhibitor
etoposide IV
6
PD1 inhibitor
pembrolizumab
7
PARP inhibitor
olaparib
8
mTOR inhibitor
everolimus
9
EGFR inhibitor
icotinib
EP
BEP
GemOx
VC
10
Chemotherapy
CaT
TI-CE
VAC
VeIP
TIP
VIP
11
MEK inhibitor
MEK inhibitor
12
Tubulin polymerization promoter, DNA synthesis inhibitor, DNA cross linking agent
paclitaxel + gemcitabine + oxaliplatin
13
Microtubule stabilizer, Tubulin polymerization promoter
docetaxel
carboplatin + docetaxel
14
Antioxidant, Bifunctional alkylating agent, Topoisomerase II inhibitor, DNA inhibitor, DNA synthesis inhibitor
cisplatin + ifosfamide + etoposide oral + mesna
15
DNA synthesis inhibitor
cisplatin
16
Topoisomerase II inhibitor, DNA inhibitor
etoposide oral
No biomarker
TMB-H
MSI-H/dMMR
BRCA1 mutation
EGFR L858R
MTOR mutation
KRAS amplification
BRCA1 expression
Chr t(22)
XPA expression
BAX underexpression
TP53 mutation
PLAC8 overexpression
RAD51C expression